In the P301L Tau model, TREM2 deletion does not show brain atrophy; however, in a double transgenic mouse model where progressive Tau aggregation is driven by mutant Aβ, Trem2 deficiency amplified Tau oligomerization and spreading, culminating in brain atrophy (Fig. 4B) (208). The gene discussed is MAPT; the disease is Brain atrophy.